Genomics may be the key to identifying, curing and preventing diseases, changing the life sciences industry as we know it. So, what does the future of genomics look like?

In this discussion, industry experts explore:

• The unique innovation advantages and challenges larger NYSE companies face compared to smaller biotechs.
• How to democratize access to essential data across the R&D value chain.
• The critical importance of implementing and complying with appropriate consent policies and procedures.

Watch a sneak peek of the webinar below: 

Watch the full webinar to learn more.